IVD Reagents

Please pay attention to the revision of the document that must be the same as the revision reported in the box label.
In case of discrepancy please contact our Customer Care e-mail: info@adaltis.net.

* Other document related to the product available at Documentation Centre and it is accessible for Adaltis distributors/partners after registration only.

The Pchem CK-MB Reagent Kit has been designed for use in the quantitative determination in vitro of the concentration of the Creatine Kinase MB in human serum and plasma. The results of the test must always be interpreted in conjunction with the clinical picture.

This kit is intended for In vitro diagnostic use only, must not be sold to the general public and the test has to be carried out by a health-care professional person.

The kit contains reagents sufficient for 454 tests.

Creatine kinase exists in 3 cytoplasmic forms: CK-MB (in cardiac muscle only), CK-MM (in striated and cardiac muscle) and CK BB (especially in brain).

Determination of CK in serum is used for the diagnosis and the follow-up of cardiac muscle damages. In myocardial infarction, the rates of total CK and CK-MB increase quickly until reaching a peak 10-24h after the onset of the infarction. The levels return to normal within 3 to 4 days. CK-MB levels higher than normal can also be observed after muscle damages.

CKMB SL reagent contains an antibody inhibiting specifically CK-M subunits (i.e. 100% of CK-MM and 50% of CK-MB isozymes). The remaining activity, corresponding to CK-B fraction activity, is measured according to the IFCC reference method for measuring CK activity. CK-MB activity is then obtained by multi plying by 2 the remaining activity.

Pchem CK-MB Reagent Kit

Code ADA-R0200000401

Reagent 1 (R1) – 2 x 48.5 mL/vial

Reagent 2 (R2) – 2 x 10 mL/vial   

• Dedicated Calibrators
• Dedicated Controls

• Dedicated Calibrators
• Dedicated Controls